The Asia Pacific Prebiotics market size is estimated to reach USD 4.38 billion by 2030, registering to grow at a CAGR of 12.4% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing gastrointestinal tract diseases like irritable bowel syndrome, have raised concerns about gut health which is likely to augment the growth of the prebiotics market in Asia Pacific.
Consumers have started consuming foods such as yogurt, apples, whole grains, and miso, that aid in improving digestion by increasing the good bacteria in the gut, along with reducing constipation. Thus, the incorporation of functional ingredients such as carotenoids, prebiotics and probiotics, fatty acids, dietary fibers, vitamins, and minerals, is likely to increase, which, in turn, is projected to benefit market growth.
Prebiotics stimulate the growth of healthy bacteria like lactobacilli in the gut and enhance pathogen resistance. This effect is induced by consuming functional foods that contain FOS, GOS, with prebiotic function. Growing gut problems among consumers have impelled them to switch to prebiotics-rich food that is likely to drive their demand for prebiotics in the coming years.
Besides, since the pandemic outbreak, consumers have been gradually selecting products that are nutritionally rich in order to maintain optimum health. This shifting trend is evident from the increased demand for nutraceuticals in the first and second quarters of 2020 throughout the world. Rising concerns regarding immunity are likely to benefit plant-based functional ingredients in the coming years.
Request a free sample copy or view report summary: Asia Pacific Prebiotics Market Report
The inulin segment dominated the Asia Pacific prebiotics market, with a revenue share of 26.9% in 2024.
The roots segment dominated the Asia Pacific prebiotics industry with the largest revenue share in 2024.
The powder/crystal form segment dominated the regional market in 2024. Powder/crystal-based prebiotics are mainly used to process nutritional dairy products, snacks, cereals, and infant foods.
The food & beverages segment dominated the Asia Pacific prebiotics market in 2024.
The gut health segment dominated the prebiotics market with the highest revenue share in 2024.
Grand View Research has segmented the Asia Pacific prebiotics market based on product, source, form, application, functionality, and country:
Asia Pacific Prebiotics Product Outlook (Revenue, USD Million, 2018 - 2030)
Inulin
Fructooligosaccharides (FOS)
Mannan-oligosaccharides (MOS)
Galacto-oligosaccharides (GOS)
Xylo-oligosaccharides (XOS)
Resistant maltodextrin
Isomalto-oligosaccharides
Resistant starch
Beta-glucans
Others
Asia Pacific Prebiotics Source Outlook (Revenue, USD Million, 2018 - 2030)
Roots
Fruits & Vegetables
Cereal & Grains
Others
Asia Pacific Prebiotics Form Outlook (Revenue, USD Million, 2018 - 2030)
Powder/crystal
Liquid
Asia Pacific Prebiotics Application Outlook (Revenue, USD Million, 2018 - 2030)
Food & Beverages
Dairy Products
Infant Foods
Cereals
Beverages
Meat Products
Others
Dietary Supplements
Food Supplements
Nutritional Supplements
Specialty Supplements
Animal Feed
Poultry
Swine
Cattle
Aquaculture
Pet Food
Asia Pacific Prebiotics Functionality Outlook (Revenue, USD Million, 2018 - 2030)
Gut Health
Cardiovascular Health
Bone Health
Immunity
Weight Management
Others
Asia Pacific Prebiotics Country Outlook (Revenue, USD Million, 2018 - 2030)
China
India
Japan
Taiwan
Australia
Thailand
Malaysia
Indonesia
Philippines
Vietnam
Singapore
South Korea
List of Key Players in Asia Pacific Prebiotics Market
BAOLINGBAO BIOLOGY CO., LTD.
Tata Chemicals Ltd.
Quantum Hi-Tech (Guangdong) Biological Co., Ltd.
Samyang Holdings Corporation
CJ CHEILJEDANG CORP.
Meiji Holdings Co., Ltd.
Layn Natural Ingredients
Fuji Nihon Corporation
"The quality of research they have done for us has been excellent..."